Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases
- PMID: 37546552
- PMCID: PMC10401465
- DOI: 10.4251/wjgo.v15.i7.1174
Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases
Abstract
Pepsinogen, secreted from the gastric mucosa, is the precursor of pepsin. It is categorized as pepsinogen 1 and pepsinogen 2 based on its immunogenicity. The pepsinogen content that can enter the blood circulation through the capillaries of the gastric mucosa is approximately 1% and remains stable all the time. The pepsinogen content in serum will change with the pathological changes of gastric mucosa. Therefore, the level of pepsinogen in serum can play a role in serologic biopsy to reflect the function and morphology of different regions of gastric mucosa and serve as an indicator of gastric disease. This study conducts relevant research on serum pepsinogen 1, pepsinogen 2, and the ratio of pepsinogen 1 to pepsinogen 2, and reviews their important value in clinical diagnosis of Helicobacter pylori infection, gastric ulcer, and even gastric carcinoma, providing ideas for other researchers.
Keywords: Gastric diseases; Pepsinogen 1; Pepsinogen 2; Serological biopsy; Serological marker.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Figures
Similar articles
-
[Potentialities of a serological method in diagnosis of atrophic gastritis].Ter Arkh. 2008;80(2):15-21. Ter Arkh. 2008. PMID: 18372589 Russian.
-
Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.Gastric Cancer. 2013 Jul;16(3):329-37. doi: 10.1007/s10120-012-0185-y. Epub 2012 Aug 21. Gastric Cancer. 2013. PMID: 22907485
-
Severe atrophic gastritis with Helicobacter pylori infection and gastric cancer.Gastric Cancer. 1998 Mar;1(2):118-124. doi: 10.1007/s101200050005. Gastric Cancer. 1998. PMID: 11957055
-
The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature.Scand J Gastroenterol Suppl. 2002;(236):22-6. doi: 10.1080/003655202320621418. Scand J Gastroenterol Suppl. 2002. PMID: 12408500 Review.
-
Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.Arch Iran Med. 2016 Feb;19(2):137-40. Arch Iran Med. 2016. PMID: 26838085 Review.
Cited by
-
Molecular Alterations in Gastric Intestinal Metaplasia Shed Light on Alteration of Methionine Metabolism: Insight into New Diagnostic and Treatment Approaches.Biomedicines. 2025 Apr 15;13(4):964. doi: 10.3390/biomedicines13040964. Biomedicines. 2025. PMID: 40299656 Free PMC article. Review.
-
Value of serum pepsinogen ratio screening for early gastric cancer and precancerous lesions in Youcheng area.World J Gastrointest Surg. 2024 Dec 27;16(12):3729-3736. doi: 10.4240/wjgs.v16.i12.3729. World J Gastrointest Surg. 2024. PMID: 39734444 Free PMC article.
-
Helicobacter pylori-related serum indicators: Cutting-edge advances to enhance the efficacy of gastric cancer screening.World J Gastrointest Oncol. 2025 Mar 15;17(3):100739. doi: 10.4251/wjgo.v17.i3.100739. World J Gastrointest Oncol. 2025. PMID: 40092953 Free PMC article. Review.
-
A preliminary exploration of a predictive model and nomogram for the efficacy of compound digestive enzyme therapy based on serum (PGI, PGII, VIP, and PRDX1) in patients with functional dyspepsia.BMC Gastroenterol. 2025 May 28;25(1):413. doi: 10.1186/s12876-025-04024-5. BMC Gastroenterol. 2025. PMID: 40437392 Free PMC article.
-
Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesions.Chin J Cancer Res. 2025 Apr 30;37(2):154-164. doi: 10.21147/j.issn.1000-9604.2025.02.03. Chin J Cancer Res. 2025. PMID: 40353072 Free PMC article.
References
-
- Rotter JI, Sones JQ, Samloff IM, Richardson CT, Gursky JM, Walsh JH, Rimoin DL. Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med. 1979;300:63–66. - PubMed
-
- Di Mario F, Crafa P, Barchi A, Franzoni L, Franceschi M, Russo M, Bricca L, Brozzi L, Rodriguez Castro K, Rugge M. Pepsinogen II in gastritis and Helicobacter pylori infection. Helicobacter. 2022;27:e12872. - PubMed
Publication types
LinkOut - more resources
Full Text Sources